
Alexandra Rojek, MD, discusses efforts to improve the safety and efficacy of CAR T-cell therapies in lymphoma through ongoing research.
Alexandra Rojek, MD, is an instructor in medicine in the Biological Sciences Division at The University of Chicago.

February 20th 2026